# Structured Regulatory Workflow Simulation

- Report ID: `workflow_simulation_20260417_221400`
- Executed At (UTC): `2026-04-17T22:16:16.572009`
- Passed Steps: `49`
- Failed Steps: `11`
- Reports Generated: `5`

## Step Results

### standard | Step 1 - Submission intake and familiarization
- Passed: `True`
- Abstained: `False`
- Prompt: `Summarize this submission, including dossier ID, applicant, product, active ingredient, dosage form, strength, and review pathway.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

**AMR Stewardship Analysis:** Th
```

### standard | Step 2 - Administrative completeness review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review the administrative completeness of this dossier and list any missing mandatory administrative documents or formal eligibility problems.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

**AMR Stewardship Analysis:** Th
```

### standard | Step 3 - Structural dossier mapping
- Passed: `True`
- Abstained: `False`
- Prompt: `Map the dossier structure, identify major sections and annex-like evidence, and flag any missing, empty, or unreadable required sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

**AMR Stewardship Analysis:** The product is classified under the **ACCESS** category. Access-category antibiotic remain
```

### standard | Step 4 - Applicable rules and requirements identification
- Passed: `False`
- Abstained: `True`
- Prompt: `Identify the applicable review rules, naming rules, product-type rules, and AMR stewardship rules that apply to this dossier.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### standard | Step 5 - WHO INN similarity review
- Passed: `True`
- Abstained: `False`
- Prompt: `Perform the WHO INN similarity review. State the proposed product name, WHO INN matched, similarity index, threshold result, interpretation, and whether naming blocks acceptance.`
- Notes: INN similarity step should explicitly mention the computed naming review.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

### WHO Guidelines Alignment

Th
```

### standard | Step 6 - Section-by-section technical review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review all major dossier sections for presence, adequacy, rule compliance, and missing evidence. List non-compliant or partially compliant sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

**AMR Stewardship Analysis:** Th
```

### standard | Step 7 - AMR stewardship review using AWaRe rules
- Passed: `True`
- Abstained: `False`
- Prompt: `If this product is antimicrobial, perform the AMR stewardship review using AWaRe rules, including category, restrictions, fast-track status, and stewardship caution. If not applicable, say so explicitly.`
- Notes: AMR step should explicitly resolve AWaRe or clearly state not applicable.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

### WHO Guidelines Alignment

Th
```

### standard | Step 8 - Identification and recording of findings
- Passed: `True`
- Abstained: `False`
- Prompt: `Record all findings identified so far, with the workflow step, violated rule, location in dossier, severity, and recommended follow-up.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern. The dossier originates from **Uganda**.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review 
```

### standard | Step 9 - Severity classification
- Passed: `True`
- Abstained: `False`
- Prompt: `Classify the identified findings by severity as critical, major, minor, or advisory, and explain which ones block acceptance.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

**AMR Stewardship Analysis:** The product is classified under the **ACCESS** category. Access-category antibiotic remain
```

### standard | Step 10 - Cross-section consistency review
- Passed: `True`
- Abstained: `False`
- Prompt: `Check cross-section consistency for product identity, active ingredient, manufacturing site, shelf-life claims, clinical claims, and antimicrobial positioning.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern. The primary manufacturing site is identified as **Workflow Manufacturer**, located in **Uganda**.

### Naming Policy Comp
```

### standard | Step 11 - Review completeness confirmation
- Passed: `False`
- Abstained: `False`
- Prompt: `Confirm whether all mandatory workflow steps have been completed, including INN similarity review and AMR stewardship where relevant.`
- Notes: Completeness step should explicitly state whether the workflow is complete.; Step failed its workflow expectation.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

**AMR Stewardship Analysis:** Th
```

### standard | Step 12 - Overall judgment
- Passed: `True`
- Abstained: `False`
- Prompt: `Based on the complete structured review, give the overall judgment as acceptable, acceptable with conditions, requires revision, not acceptable, or escalate for higher review, with justification.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Standard Review Demo** (nitrofurantoin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Compliance

No INN infringement detected for 'Standard Review Demo'.

**AMR Stewardship Analysis:** Th
```

### watch | Step 1 - Submission intake and familiarization
- Passed: `True`
- Abstained: `False`
- Prompt: `Summarize this submission, including dossier ID, applicant, product, active ingredient, dosage form, strength, and review pathway.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

**AMR Stewardship Analys
```

### watch | Step 2 - Administrative completeness review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review the administrative completeness of this dossier and list any missing mandatory administrative documents or formal eligibility problems.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

**AMR Stewardship Analys
```

### watch | Step 3 - Structural dossier mapping
- Passed: `True`
- Abstained: `False`
- Prompt: `Map the dossier structure, identify major sections and annex-like evidence, and flag any missing, empty, or unreadable required sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **WATCH** category. Watch-category antibiot
```

### watch | Step 4 - Applicable rules and requirements identification
- Passed: `False`
- Abstained: `True`
- Prompt: `Identify the applicable review rules, naming rules, product-type rules, and AMR stewardship rules that apply to this dossier.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### watch | Step 5 - WHO INN similarity review
- Passed: `True`
- Abstained: `False`
- Prompt: `Perform the WHO INN similarity review. State the proposed product name, WHO INN matched, similarity index, threshold result, interpretation, and whether naming blocks acceptance.`
- Notes: INN similarity step should explicitly mention the computed naming review.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

### WHO Guidelines Align
```

### watch | Step 6 - Section-by-section technical review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review all major dossier sections for presence, adequacy, rule compliance, and missing evidence. List non-compliant or partially compliant sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

**AMR Stewardship Analys
```

### watch | Step 7 - AMR stewardship review using AWaRe rules
- Passed: `True`
- Abstained: `False`
- Prompt: `If this product is antimicrobial, perform the AMR stewardship review using AWaRe rules, including category, restrictions, fast-track status, and stewardship caution. If not applicable, say so explicitly.`
- Notes: AMR step should explicitly resolve AWaRe or clearly state not applicable.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

### WHO Guidelines Align
```

### watch | Step 8 - Identification and recording of findings
- Passed: `True`
- Abstained: `False`
- Prompt: `Record all findings identified so far, with the workflow step, violated rule, location in dossier, severity, and recommended follow-up.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns. The dossier originates from **Uganda**.

### Naming Policy Compliance

No INN infringement detected for 'Watch
```

### watch | Step 9 - Severity classification
- Passed: `True`
- Abstained: `False`
- Prompt: `Classify the identified findings by severity as critical, major, minor, or advisory, and explain which ones block acceptance.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **WATCH** category. Watch-category antibiot
```

### watch | Step 10 - Cross-section consistency review
- Passed: `True`
- Abstained: `False`
- Prompt: `Check cross-section consistency for product identity, active ingredient, manufacturing site, shelf-life claims, clinical claims, and antimicrobial positioning.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns. The primary manufacturing site is identified as **Workflow Manufacturer**, located in **Uganda**.

### Naming 
```

### watch | Step 11 - Review completeness confirmation
- Passed: `False`
- Abstained: `False`
- Prompt: `Confirm whether all mandatory workflow steps have been completed, including INN similarity review and AMR stewardship where relevant.`
- Notes: Completeness step should explicitly state whether the workflow is complete.; Step failed its workflow expectation.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

**AMR Stewardship Analys
```

### watch | Step 12 - Overall judgment
- Passed: `True`
- Abstained: `False`
- Prompt: `Based on the complete structured review, give the overall judgment as acceptable, acceptable with conditions, requires revision, not acceptable, or escalate for higher review, with justification.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Watch Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Watch Review Demo'.

**AMR Stewardship Analys
```

### quality_failure | Step 1 - Submission intake and familiarization
- Passed: `True`
- Abstained: `False`
- Prompt: `Summarize this submission, including dossier ID, applicant, product, active ingredient, dosage form, strength, and review pathway.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

**AMR Stewardship An
```

### quality_failure | Step 2 - Administrative completeness review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review the administrative completeness of this dossier and list any missing mandatory administrative documents or formal eligibility problems.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

**AMR Stewardship An
```

### quality_failure | Step 3 - Structural dossier mapping
- Passed: `True`
- Abstained: `False`
- Prompt: `Map the dossier structure, identify major sections and annex-like evidence, and flag any missing, empty, or unreadable required sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **WATCH** category. Watch-category antibi
```

### quality_failure | Step 4 - Applicable rules and requirements identification
- Passed: `False`
- Abstained: `True`
- Prompt: `Identify the applicable review rules, naming rules, product-type rules, and AMR stewardship rules that apply to this dossier.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### quality_failure | Step 5 - WHO INN similarity review
- Passed: `True`
- Abstained: `False`
- Prompt: `Perform the WHO INN similarity review. State the proposed product name, WHO INN matched, similarity index, threshold result, interpretation, and whether naming blocks acceptance.`
- Notes: INN similarity step should explicitly mention the computed naming review.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

### WHO Guidelines A
```

### quality_failure | Step 6 - Section-by-section technical review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review all major dossier sections for presence, adequacy, rule compliance, and missing evidence. List non-compliant or partially compliant sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

**AMR Stewardship An
```

### quality_failure | Step 7 - AMR stewardship review using AWaRe rules
- Passed: `True`
- Abstained: `False`
- Prompt: `If this product is antimicrobial, perform the AMR stewardship review using AWaRe rules, including category, restrictions, fast-track status, and stewardship caution. If not applicable, say so explicitly.`
- Notes: AMR step should explicitly resolve AWaRe or clearly state not applicable.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

### WHO Guidelines A
```

### quality_failure | Step 8 - Identification and recording of findings
- Passed: `True`
- Abstained: `False`
- Prompt: `Record all findings identified so far, with the workflow step, violated rule, location in dossier, severity, and recommended follow-up.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns. The dossier originates from **Uganda**.

### Naming Policy Compliance

No INN infringement detected for 'Sca
```

### quality_failure | Step 9 - Severity classification
- Passed: `True`
- Abstained: `False`
- Prompt: `Classify the identified findings by severity as critical, major, minor, or advisory, and explain which ones block acceptance.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **WATCH** category. Watch-category antibi
```

### quality_failure | Step 10 - Cross-section consistency review
- Passed: `True`
- Abstained: `False`
- Prompt: `Check cross-section consistency for product identity, active ingredient, manufacturing site, shelf-life claims, clinical claims, and antimicrobial positioning.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns. The primary manufacturing site is identified as **Workflow Manufacturer**, located in **Uganda**.

### Namin
```

### quality_failure | Step 11 - Review completeness confirmation
- Passed: `False`
- Abstained: `False`
- Prompt: `Confirm whether all mandatory workflow steps have been completed, including INN similarity review and AMR stewardship where relevant.`
- Notes: Completeness step should explicitly state whether the workflow is complete.; Step failed its workflow expectation.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Additional Information Required**. The submission covers the product **Scanned Review Demo** (levofloxacin), submitted by **Workflow Applicant**. The structured review found **3** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Scanned Review Demo'.

**AMR Stewardship An
```

### quality_failure | Step 12 - Overall judgment
- Passed: `False`
- Abstained: `True`
- Prompt: `Based on the complete structured review, give the overall judgment as acceptable, acceptable with conditions, requires revision, not acceptable, or escalate for higher review, with justification.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### naming_conflict | Step 1 - Submission intake and familiarization
- Passed: `True`
- Abstained: `False`
- Prompt: `Summarize this submission, including dossier ID, applicant, product, active ingredient, dosage form, strength, and review pathway.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 2 - Administrative completeness review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review the administrative completeness of this dossier and list any missing mandatory administrative documents or formal eligibility problems.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 3 - Structural dossier mapping
- Passed: `True`
- Abstained: `False`
- Prompt: `Map the dossier structure, identify major sections and annex-like evidence, and flag any missing, empty, or unreadable required sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 4 - Applicable rules and requirements identification
- Passed: `False`
- Abstained: `True`
- Prompt: `Identify the applicable review rules, naming rules, product-type rules, and AMR stewardship rules that apply to this dossier.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### naming_conflict | Step 5 - WHO INN similarity review
- Passed: `True`
- Abstained: `False`
- Prompt: `Perform the WHO INN similarity review. State the proposed product name, WHO INN matched, similarity index, threshold result, interpretation, and whether naming blocks acceptance.`
- Notes: INN similarity step should explicitly mention the computed naming review.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 6 - Section-by-section technical review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review all major dossier sections for presence, adequacy, rule compliance, and missing evidence. List non-compliant or partially compliant sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 7 - AMR stewardship review using AWaRe rules
- Passed: `True`
- Abstained: `False`
- Prompt: `If this product is antimicrobial, perform the AMR stewardship review using AWaRe rules, including category, restrictions, fast-track status, and stewardship caution. If not applicable, say so explicitly.`
- Notes: AMR step should explicitly resolve AWaRe or clearly state not applicable.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 8 - Identification and recording of findings
- Passed: `True`
- Abstained: `False`
- Prompt: `Record all findings identified so far, with the workflow step, violated rule, location in dossier, severity, and recommended follow-up.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern. The dossier originates from **Uganda**.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicilli
```

### naming_conflict | Step 9 - Severity classification
- Passed: `True`
- Abstained: `False`
- Prompt: `Classify the identified findings by severity as critical, major, minor, or advisory, and explain which ones block acceptance.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 10 - Cross-section consistency review
- Passed: `True`
- Abstained: `False`
- Prompt: `Check cross-section consistency for product identity, active ingredient, manufacturing site, shelf-life claims, clinical claims, and antimicrobial positioning.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern. The primary manufacturing site is identified as **Workflow Manufacturer**, located in **Uganda**.

### Naming Policy Violation

Produc
```

### naming_conflict | Step 11 - Review completeness confirmation
- Passed: `False`
- Abstained: `False`
- Prompt: `Confirm whether all mandatory workflow steps have been completed, including INN similarity review and AMR stewardship where relevant.`
- Notes: Completeness step should explicitly state whether the workflow is complete.; Step failed its workflow expectation.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### naming_conflict | Step 12 - Overall judgment
- Passed: `True`
- Abstained: `False`
- Prompt: `Based on the complete structured review, give the overall judgment as acceptable, acceptable with conditions, requires revision, not acceptable, or escalate for higher review, with justification.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Denied**. The submission covers the product **amoxicillin** (amoxicillin), submitted by **Workflow Applicant**. The structured review found **1** unresolved requirement-level concern.

### Naming Policy Violation

Product name 'amoxicillin' has 0.92 similarity to INN 'ampicillin' (Threshold: 0.7).

A recommendation t
```

### reserve_fast_track | Step 1 - Submission intake and familiarization
- Passed: `True`
- Abstained: `False`
- Prompt: `Summarize this submission, including dossier ID, applicant, product, active ingredient, dosage form, strength, and review pathway.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

**AMR Stewardship Analysis:** The pr
```

### reserve_fast_track | Step 2 - Administrative completeness review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review the administrative completeness of this dossier and list any missing mandatory administrative documents or formal eligibility problems.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

**AMR Stewardship Analysis:** The pr
```

### reserve_fast_track | Step 3 - Structural dossier mapping
- Passed: `True`
- Abstained: `False`
- Prompt: `Map the dossier structure, identify major sections and annex-like evidence, and flag any missing, empty, or unreadable required sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **RESERVE** category. Reserve antibiotic targets a critic
```

### reserve_fast_track | Step 4 - Applicable rules and requirements identification
- Passed: `False`
- Abstained: `True`
- Prompt: `Identify the applicable review rules, naming rules, product-type rules, and AMR stewardship rules that apply to this dossier.`
- Notes: Step should complete without abstention and produce a grounded answer.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### reserve_fast_track | Step 5 - WHO INN similarity review
- Passed: `True`
- Abstained: `False`
- Prompt: `Perform the WHO INN similarity review. State the proposed product name, WHO INN matched, similarity index, threshold result, interpretation, and whether naming blocks acceptance.`
- Notes: INN similarity step should explicitly mention the computed naming review.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

### WHO Guidelines Alignment

The pr
```

### reserve_fast_track | Step 6 - Section-by-section technical review
- Passed: `True`
- Abstained: `False`
- Prompt: `Review all major dossier sections for presence, adequacy, rule compliance, and missing evidence. List non-compliant or partially compliant sections.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

**AMR Stewardship Analysis:** The pr
```

### reserve_fast_track | Step 7 - AMR stewardship review using AWaRe rules
- Passed: `True`
- Abstained: `False`
- Prompt: `If this product is antimicrobial, perform the AMR stewardship review using AWaRe rules, including category, restrictions, fast-track status, and stewardship caution. If not applicable, say so explicitly.`
- Notes: AMR step should explicitly resolve AWaRe or clearly state not applicable.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

### WHO Guidelines Alignment

The pr
```

### reserve_fast_track | Step 8 - Identification and recording of findings
- Passed: `True`
- Abstained: `False`
- Prompt: `Record all findings identified so far, with the workflow step, violated rule, location in dossier, severity, and recommended follow-up.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns. The dossier originates from **Uganda**.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo
```

### reserve_fast_track | Step 9 - Severity classification
- Passed: `True`
- Abstained: `False`
- Prompt: `Classify the identified findings by severity as critical, major, minor, or advisory, and explain which ones block acceptance.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

**AMR Stewardship Analysis:** The product is classified under the **RESERVE** category. Reserve antibiotic targets a critic
```

### reserve_fast_track | Step 10 - Cross-section consistency review
- Passed: `True`
- Abstained: `False`
- Prompt: `Check cross-section consistency for product identity, active ingredient, manufacturing site, shelf-life claims, clinical claims, and antimicrobial positioning.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns. The primary manufacturing site is identified as **Workflow Manufacturer**, located in **Uganda**.

### Naming Policy Complia
```

### reserve_fast_track | Step 11 - Review completeness confirmation
- Passed: `False`
- Abstained: `True`
- Prompt: `Confirm whether all mandatory workflow steps have been completed, including INN similarity review and AMR stewardship where relevant.`
- Notes: Completeness step should explicitly state whether the workflow is complete.; Step failed its workflow expectation.
- Response excerpt:

```text
Abstained because no evidence chunks were retrieved for the request.
```

### reserve_fast_track | Step 12 - Overall judgment
- Passed: `True`
- Abstained: `False`
- Prompt: `Based on the complete structured review, give the overall judgment as acceptable, acceptable with conditions, requires revision, not acceptable, or escalate for higher review, with justification.`
- Notes: Step should complete without abstention and produce a grounded answer.
- Response excerpt:

```text
### Final Answer

### Executive Summary

The current grounded regulatory recommendation is **Approval Granted**. The submission covers the product **Reserve Review Demo** (cefiderocol), submitted by **Workflow Applicant**. The structured review found **2** unresolved requirement-level concerns.

### Naming Policy Compliance

No INN infringement detected for 'Reserve Review Demo'.

**AMR Stewardship Analysis:** The pr
```

## Generated Reports

- `WF-STANDARD-20260417_221400` (standard): passed=True, final_verdict=acceptable, json=/v1/reports/report-c0211d86226f/json
- `WF-WATCH-20260417_221400` (watch): passed=True, final_verdict=requires_revision, json=/v1/reports/report-734e67fc6184/json
- `WF-QUALITY_FAILURE-20260417_221400` (quality_failure): passed=True, final_verdict=escalate_for_higher_review, json=/v1/reports/report-ae79381d663b/json
- `WF-NAMING_CONFLICT-20260417_221400` (naming_conflict): passed=True, final_verdict=not_acceptable, json=/v1/reports/report-1d61b73cb2ab/json
- `WF-RESERVE_FAST_TRACK-20260417_221400` (reserve_fast_track): passed=True, final_verdict=acceptable_with_conditions, json=/v1/reports/report-b3712ad1a9de/json